Frontiers | Nine Things Genomics Can Tell Us About Candida auris
Candida auris: A systematic review and meta‐analysis of current updates on an emerging multidrug‐resistant pathogen - Osei Sekyere - 2018 - MicrobiologyOpen - Wiley Online Library
MIC50, MIC90, MIC range and geometric mean of five antifungal agents... | Download Scientific Diagram
Frontiers | Silver Nanoantibiotics Display Strong Antifungal Activity Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both Planktonic and Biofilm Growing Conditions
How to interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST) - Clinical Microbiology and Infection
Modulation of key antioxidant enzymes and cell cycle arrest as a possible antifungal mode of action of cinnamaldehyde based azole derivative - ScienceDirect
Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019–2022 | Infection Control & Hospital Epidemiology | Cambridge Core
Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values | Antimicrobial Agents and Chemotherapy
Candida auris: MDR Fungus Among Us
Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019
AST News Update 2019 Practical Tips 1: AST For Candida Species
Candida auris: MDR Fungus Among Us
Frontiers | Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris
C. auris strains were collected from Montefiore Medical Center (MMC)... | Download Scientific Diagram
Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values | Antimicrobial Agents and Chemotherapy
Clinical, microbiological, and genomic characteristics of clade-III Candida auris colonization and infection in southern California, 2019–2022 | Infection Control & Hospital Epidemiology | Cambridge Core
In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris | bioRxiv
Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait | PLOS ONE
Candida auris: Diagnostic Challenges and Emerging Opportunities for the Clinical Microbiology Laboratory | SpringerLink
Antifungal Resistance Trends of Candida auris Clinical Isolates in New York and New Jersey from 2016 to 2020 | Antimicrobial Agents and Chemotherapy
![PDF] First reported case of multidrug-resistant Candida auris in Canada. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ae0bea639831fb9878b2b64c7718e62901286483/2-Table1-1.png "PDF] First reported case of multidrug-resistant Candida auris in Canada. | Semantic Scholar")